Victoria Socha

Articles by Victoria Socha

Victoria SochaGout | June 10, 2025
Cryo-electron microscopy shed light on the molecular structure of urate transporter 1 and mechanisms behind four gout drugs.
Victoria SochaGout | June 9, 2025
Gene sequencing of a patient with gouty sacroiliitis and gouty nephropathy highlighted genetic factors leading to gout.
Victoria SochaIgA Nephropathy | June 6, 2025
Infliximab therapy for Crohn’s disease is linked to a high risk for IgAN, a study found.
Victoria SochaIgA Nephropathy | June 5, 2025
Moderate-to-severe chronic arteriolar lesions were found to be independent risk factors for adverse renal prognosis in IgAN.
Victoria SochaEnd-Stage Renal Disease | June 4, 2025
Pain coping skills training demonstrated benefits for patients on maintenance hemodialysis in a randomized clinical trial.
Victoria SochaEnd-Stage Renal Disease | June 3, 2025
Hemodialysis patients reporting shorter sleep or problems sleeping had a higher mortality risk in an observational study.
Victoria SochaChronic Kidney Disease | June 2, 2025
Finerenone had kidney and cardiovascular benefits for patients with CKD even after an acute eGFR change occurred.
Victoria SochaNephrology Times | May 30, 2025
Higher cardiovascular mortality risk was associated with higher CKM syndrome stage, research showed.
Victoria SochaChronic Kidney Disease | May 29, 2025
A dual SGLT inhibitor may have ischemic benefits for patients with CKD, T2D, and cardiovascular risks, a study found.
Victoria SochaChronic Kidney Disease | May 28, 2025
An analysis of CKD trials supported 3-year total slope as the primary slope-based outcome in randomized trials.
Victoria SochaNephrology Times | May 27, 2025
Cyclophosphamide-rituximab therapy and minimal use of glucocorticoids in ANCA-associated vasculitis may reduce morbidity.
Victoria SochaADPKD | May 26, 2025
The race of patients with ADPKD affects waitlist experience, allograft quality, and post-transplant outcomes, a study found.
Victoria SochaADPKD | May 23, 2025
A study of real-world data found that tolvaptan reduced long-term kidney function decline in ADPKD.
Victoria SochaAcute Kidney Injury | May 22, 2025
Using serum cystatin C as a biomarker for AKI could prove to be a valuable addition to diagnostic protocols, a study reports.
Victoria SochaDiabetes and Hypertension | May 28, 2025
Researchers examined the effects of the GLP-1RA cotadutide on UACR, glycemic control, and body weight.
Victoria SochaChronic Kidney Disease | May 12, 2025
A meta-analysis examined the risk of CKD in patients with metabolic dysfunction-associated fatty liver disease.
Victoria SochaIgA Nephropathy | May 14, 2025
An analysis Identified SIRT1, BAG3, COKN1A and FOS as potential autophagy-related biomarkers for IgAN.
Victoria SochaIgA Nephropathy | May 14, 2025
Research identified microRNA-483-5p as a possible biomarker for IgA nephropathy to help with risk stratification.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 18, 2025
A survey sought insight on nephrologists' practices and perceptions about reproductive care for women with kidney disease.
Victoria SochaNKF Spring Clinical Meetings 2025 | April 17, 2025
A study examined the effects of SGLT2i on eGFR slope in patients with autosomal dominant polycystic kidney disease.